RxDoctor Payments Data

Muna Vonderheide, APRN

Women's Health · Ashland, KYNPI 1952689598

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 31.6% of the total. Reporting peaked in 2022 at $341 and has fallen 73.6% since, to $90 in 2025.

$863in general payments, 2019–2025

Across 45 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$273
  • Pfizer$70
  • Biohaven Pharmaceutical Holding Company Ltd.$66
  • Novo Nordisk$63
  • Gilead$60
  • Lilly USA, LLC$47
  • plus $284 from 13 others

What the payments were for

  • Food & beverage$863100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$863 in reported general payments places this provider in the 60th percentile of 96 women's health providers in Kentucky.

See all women's health providers in Kentucky

Medicare billing

Part B allowed, 2024
$66
Medicare patients
11
Services billed
11

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rosuvastatin Calcium16$857
DottiEstradiol13$837
Medroxyprogesterone Acetate19$523
Omeprazole27$112
Levothyroxine Sodium16$106
Metformin Hcl ErMetformin Hcl11$104

Paid to pharmacies, not to this prescriber.

Other women's health in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →